INS1009-301 PALM-PAH A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Insmed Incorporated
Start Date
June 13, 2026
End Date
April 14, 2031
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Insmed Incorporated
Start Date
June 13, 2026
End Date
April 14, 2031